STOCK TITAN
  1. Home
  2. Financials
  3. VSBC
  4. EPS (Diluted)

VITASPRING BIOMEDICAL CO (VSBC) EPS by Year

VSBC

VITASPRING BIOMEDICAL CO earned $0.00 per diluted share in fiscal year 2026. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $0.00 per diluted share. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters VITASPRING BIOMEDICAL CO has filed alongside them.

FY2026 annual
EPS (Diluted) $0.00
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VSBC EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
EPS (Diluted)$0.00$0.00$0.00+100.0%-$0.01+50.0%-$0.02$0.00N/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

VSBC EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
EPS (Diluted)$0.00$0.00$0.00$0.00$0.00$0.00+100.0%$0.00$0.00$0.00-$0.01+50.0%$0.00$0.00

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More VITASPRING BIOMEDICAL CO financials

Frequently Asked Questions

What was VITASPRING BIOMEDICAL CO's diluted earnings per share in fiscal year 2026?

VITASPRING BIOMEDICAL CO earned $0.00 per diluted share in fiscal year 2026.

What is VITASPRING BIOMEDICAL CO's diluted earnings per share over the last twelve months?

VITASPRING BIOMEDICAL CO (VSBC) reported $0.00 per diluted share over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

What was VITASPRING BIOMEDICAL CO's diluted earnings per share in the most recent quarter?

VITASPRING BIOMEDICAL CO (VSBC) reported $0.00 in diluted earnings per share in Q1 2027.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what VITASPRING BIOMEDICAL CO (VSBC) reported on that line in every period on record.